Sierra’s Part D Gap Coverage For Brands Attracts Disproportionately High Rx Users
Executive Summary
Drug expenditures in Sierra Health Services's enhanced stand-alone Medicare prescription drug plan led to a $2 million after-tax loss for the plan during the month of January, Chairman and CEO Anthony Marlon said during a Feb. 27 call with securities analysts